PFBT
SLDB icon

Parkside Financial Bank & Trust’s Solid Biosciences SLDB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35K Hold
135
– – ﹤0.01% 2314
2026
Q1 		$971 Hold
135
– – ﹤0.01% 2368
2025
Q4 		$762 Hold
135
– – ﹤0.01% 2433
2025
Q3 		$832 Hold
135
– – ﹤0.01% 2360
2025
Q2 		$658 Buy
+135
New +$477 ﹤0.01% 2408

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parkside Financial Bank & Trust's SLDB Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Solid Biosciences (SLDB) position steady in Q2 2026 at 135 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2314.

Parkside Financial Bank & Trust first reported a position in SLDB in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Parkside Financial Bank & Trust held 135 shares of Solid Biosciences worth $1.35K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2314 holding.
  • Parkside Financial Bank & Trust first reported a position in Solid Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.